Journals Library

An error occurred retrieving content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

There was no evidence of an association between consultant presence in Early Pregnancy Assessment Units and clinical outcomes measured as the proportion of women who were admitted as emergencies.

{{author}}{{author}}{{($index < metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Maria Memtsa 1, Venetia Goodhart 1, Gareth Ambler 2, Peter Brocklehurst 3, Edna Keeney 4, Sergio Silverio 1,5, Zacharias Anastasiou 2, Jeff Round 6, Nazim Khan 7, Jennifer Hall 1, Geraldine Barrett 1, Ruth Bender-Atik 8, Judith Stephenson 1, Davor Jurkovic 1,*

1 Elizabeth Garrett Anderson Institute for Women’s Health, University College London, London, UK
2 Department of Statistical Science, University College London, London, UK
3 Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
4 Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
5 Department of Women and Children’s Health, King’s College London, St Thomas’ Hospital, London, UK
6 Institute of Health Economics, School of Social and Community Medicine, University of Bristol, Bristol, UK
7 Modelling and Analytical Systems Solutions Ltd, Edinburgh, UK
8 The Miscarriage Association, Wakefield, UK
* Corresponding author Email: davor.jurkovic@nhs.net

Declared competing interests of authors: Peter Brocklehurst reports personal fees from the Medical Research Council (MRC) and AG Biotest (Dreieich, Germany), and grants from the MRC, National Institute for Health Research (NIHR) Health Services and Delivery Research programme, NIHR Health Technology Assessment (HTA) programme and Wellcome Trust, outside the submitted work. At the time of the study, Peter Brocklehurst was a chairperson of the NIHR HTA Maternal, Neonatal and Child Health Panel (2014–16) and a member of the NIHR HTA Programme Commissioning Group (2010–12) and the NIHR HTA Prioritisation Group (2014–16). Edna Keeney reports personal fees from Novartis Pharmaceuticals UK Ltd (London, UK) and from Pfizer Inc. (Pfizer Inc., New York, NY, USA), outside the submitted work. Jeff Round is currently employed by the Institute of Health Economics. The Institute of Health Economics receives funding from, and collaborates with, government, academic, not-for-profit and private-sector organisations. The Institute of Health Economics does not currently receive funds for research related to the submitted work.

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

 

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions